Genomic engineering refers to the strategies and techniques implemented for the modification of target genetic information of any living organism. The genomic engineering market is growing rapidly due to large number of applications in areas such as gene mutations, therapeutics, and agricultural biotechnology.
The global genome engineering or genome editing market report provides market size (Revenue US$ Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).
The global genome engineering or genome editing market segmentation is based on technologies (clustered regularly interspaced short palindromic repeats, transcription activator-like effector nuclease, zinc finger nuclease), applications (animal genome engineering, cell line engineering, plant genome engineering), end users (academics, clinical research organizations, pharmaceutical and biotechnology companies).
The global genome engineering or genome editing market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global genome engineering or genome editing market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global genome engineering or genome editing market and included in this report are Thermo Fisher Scientific, Inc., Applied StemCell, Inc., Sangamo Biosciences, Inc., Lonza Group Ltd., and Sigma-Aldrich Corporation, and others.